The Schall Law Firm Reminds Investors of Class Action Lawsuit Against ModivCare Inc.

LOS ANGELES, CA / ACCESS Newswire / February 14, 2025

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ModivCare Inc. (“ModivCare” or “the Company”) (NASDAQ:MODV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between November 3, 2022, and September 15, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before March 31, 2025.

The Schall Law Firm has issued a reminder to investors regarding a class action lawsuit against ModivCare Inc., a well-known company in the healthcare industry. The lawsuit alleges violations of federal securities laws during a specific period when investors may have been misled.

ModivCare Inc., listed on NASDAQ under the ticker symbol MODV, is facing allegations of breaching the Securities Exchange Act of 1934 and related regulations enforced by the U.S. Securities and Exchange Commission. The alleged violations pertain to sections 10(b) and 20(a) of the Act, as well as Rule 10b-5.

Investors who bought securities of ModivCare Inc. between November 3, 2022, and September 15, 2024, are considered part of the identified “Class Period.” The Schall Law Firm urges these investors to make contact before March 31, 2025, to learn more about their rights and potential legal recourse.

Impact on Individuals

Based on online sources, this class action lawsuit against ModivCare Inc. could have a significant impact on individual investors who purchased the Company’s securities during the specified Class Period. Investors may experience financial losses if the allegations of securities law violations are proven true.

Global Implications

Furthermore, the class action lawsuit against ModivCare Inc. may have broader implications for the world of finance and investing. If the allegations are substantiated, it could raise concerns about corporate governance, transparency, and compliance within the healthcare industry.

Conclusion

In conclusion, the class action lawsuit against ModivCare Inc. initiated by The Schall Law Firm underscores the importance of investor protection and regulatory oversight in the financial markets. It serves as a reminder for investors to conduct thorough due diligence before making investment decisions and reinforces the need for companies to uphold the highest standards of ethical conduct and transparency.